9-133537512-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM2BP4_StrongBP6BP7BS1
The NM_014694.4(ADAMTSL2):c.198G>A(p.Gly66=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000621 in 1,352,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00032 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000029 ( 0 hom. )
Consequence
ADAMTSL2
NM_014694.4 synonymous
NM_014694.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.763
Genes affected
ADAMTSL2 (HGNC:14631): (ADAMTS like 2) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) and ADAMTS-like protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The protein encoded by this gene lacks the protease domain, and is therefore of a member of the the ADAMTS-like protein subfamily. It is a secreted glycoprotein that binds the cell surface and extracellular matrix; it also interacts with latent transforming growth factor beta binding protein 1. Mutations in this gene have been associated with geleophysic dysplasia. [provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 9-133537512-G-A is Benign according to our data. Variant chr9-133537512-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3352484.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.763 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000322 (49/152352) while in subpopulation AFR AF= 0.00106 (44/41582). AF 95% confidence interval is 0.000809. There are 0 homozygotes in gnomad4. There are 14 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTSL2 | NM_014694.4 | c.198G>A | p.Gly66= | synonymous_variant | 3/19 | ENST00000651351.2 | NP_055509.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTSL2 | ENST00000651351.2 | c.198G>A | p.Gly66= | synonymous_variant | 3/19 | NM_014694.4 | ENSP00000498961 | P1 | ||
ADAMTSL2 | ENST00000393061.7 | c.525G>A | p.Gly175= | synonymous_variant | 3/19 | 1 | ENSP00000376781 | |||
ADAMTSL2 | ENST00000354484.8 | c.198G>A | p.Gly66= | synonymous_variant | 3/19 | 1 | ENSP00000346478 | P1 | ||
ADAMTSL2 | ENST00000393060.1 | c.198G>A | p.Gly66= | synonymous_variant | 3/19 | 1 | ENSP00000376780 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152234Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
49
AN:
152234
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000975 AC: 12AN: 123080Hom.: 0 AF XY: 0.0000904 AC XY: 6AN XY: 66374
GnomAD3 exomes
AF:
AC:
12
AN:
123080
Hom.:
AF XY:
AC XY:
6
AN XY:
66374
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000292 AC: 35AN: 1200214Hom.: 0 Cov.: 30 AF XY: 0.0000276 AC XY: 16AN XY: 578986
GnomAD4 exome
AF:
AC:
35
AN:
1200214
Hom.:
Cov.:
30
AF XY:
AC XY:
16
AN XY:
578986
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000322 AC: 49AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74500
GnomAD4 genome
AF:
AC:
49
AN:
152352
Hom.:
Cov.:
33
AF XY:
AC XY:
14
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ADAMTSL2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 15, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at